...we are currently assessing these opportunities. It is very encouraging
to see the increased level of industry interest and willingness to support and fund further trials for efti in
cancer because of the growing body of positive data generated from efti clinical trials thus far.
At this stage, discussions with various parties are incomplete and still subject to negotiation. Once an
agreement is reached, the Company will provide further details in a market announcement....
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.8¢ |
Change
-0.003(0.57%) |
Mkt cap ! $523.0M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 43.3¢ | $298.2K | 681.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 72432 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 105109 | 14 |
View Market Depth
| Last trade - 13.29pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
43.5¢ |
Change
-0.003 ( 1.23 %) |
||||
| Open | High | Low | Volume | ||
| 43.5¢ | 44.0¢ | 43.0¢ | 272046 | ||
| Last updated 13.46pm 30/05/2024 ? | |||||
| IMM (ASX) Chart |